YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
MediPharm Labs (OTC:MEDIF) reported first-quarter financial results on Wednesday. The transcript from the company's first-quarter earnings call has been provided below. This transcript is brought to you by Benzinga APIs. For real-time acce…
* MediPharm Labs press release [https://seekingalpha.com/pr/20512994-medipharm-labs-reports-first-quarter-2026-results-achieving-positive-adjusted-ebitda] (MEDIF [https://seekingalpha.com/symbol/MEDIF]): Q1 Adjusted EBITDA of $0.1 million…
FY 2025 revenue of $45.1 million, an increase of 8% over 2024International Medical Cannabis revenue increased 43% year-over-year and represented more than 50% of total revenueIncreased cash balance of $10.8 Million at the end of Q4, up $0.…
Major earnings expected before the bell on Monday include: * Fermi (FRMI [https://seekingalpha.com/symbol/FRMI]) * Sigma Lithium Corporation (SGML [https://seekingalpha.com/symbol/SGML]) * Rezolve AI PLC (RZLV [https://seekingalpha.com/sym…
MediPharm Labs (LABS.TO) on Monday announced that David Pidduck will be stepping down from his role PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium ne…
* MediPharm Labs (LABS:CA [https://seekingalpha.com/symbol/LABS:CA]) announced on Monday that David Pidduck will be stepping down from his role as the company's chief executive officer (CEO), effective January 2, 2026. * The board of direc…
* MediPharm Labs press release [https://seekingalpha.com/pr/20305985-medipharm-advances-global-reach-in-q3-2025-with-double-digit-revenue-growth-and-strong] (OTCQB:MEDIF [https://seekingalpha.com/symbol/MEDIF]): Q3 Revenue of $11.45M (+16.…
* MediPharm Labs press release [https://seekingalpha.com/pr/20200793-medipharm-strengthens-global-position-in-q2-2025-with-14-percent-revenue-growth-and-50] (OTCQB:MEDIF [https://seekingalpha.com/symbol/MEDIF]): Q2 Revenue of $11.8 Million…
MediPharm Labs (MEDIF) announced that independent proxy voting and corporate governance advisory firm Glass, Lewis & Co. published a report on June 12 recommending that MediPharm shareholders vote the GREEN Proxy or voting instruction form…
Key Takeaways; Cannabis Sector MediPharm pushed back against Apollo’s boardroom challenge Organigram was named “Exporter of the Year” for cannabis innovation and global reach Green Thumb posted solid Q1 2025 results, as the company focuses…
TORONTO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce that it…
MediPharm Labs pharma-quality CBD dominant oil line has been awarded CBD Brand of the year by KIND Magazine.MediPharm Labs’ CBD products have seen steady revenue growth and notoriety in 2021, including on national television on an episode…
Strong cash balance and continued reduction of convertible debt to less than $500K.Opportunities for optimization of the operating strategy between Australia and Canada as the Canadian Drug Establishment Licence (DEL) unlocks many manufact…
BARRIE, Ontario, Dec. 07, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce…
Patient based delivery of medical cannabis executed with approval from both Barbados and Canadian Health Authorities. This marks the fourth new country entered by MediPharm Labs in 2021, following initial shipments to Germany, Brazil and P…
A leader in CBN products, MediPharm Labs, adds CBN:CBD products to its wellness portfolio for consumers and patients looking for a product without THC effects.New CBN products include CBN:CBD 1:2 Relax Formula Oil and a Northbound high CBN…
BARRIE, Ontario, Nov. 15, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids today announced its financial…
TORONTO, Nov. 10, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will r…
C-Suite healthcare leader, Bryan Howcroft, to lead MediPharm’s next phase of international growth as CEO. Bryan will apply his experience in registering, distributing, and selling medically registered products in the United States, Europea…
New strategic partnership through the delivery of GMP extract to Germany for Vayamed, the medical cannabis business unit of Sanity GroupVayamed is a well-established operating medical cannabis company in Germany, where the medical cannabis…
Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view the presentations NEW YORK, Sept. 13, 2021 /CNW/ - Virtual Investor Conferences® and KCSA Strategic Communications t…
Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view the presentations NEW YORK, Sept. 13, 2021 /PRNewswire/ -- Virtual Investor Conferences® and KCSA Strategic Communic…
BARRIE, Ontario, April 26, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction,…
TORONTO, ON and BAD OLDESLOE, GERMANY and GLIL YAM, ISRAEL / ACCESSWIRE / April 13, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC)(NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational canna…
TORONTO, ON and BAD OLDESLOE, GERMANY and GLIL YAM, ISRAEL / ACCESSWIRE / April 13, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC)(NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational canna…
MediPharm Labs’ high THC medical cannabis has been successfully exported to Peru for distribution by specialized compounding pharmacies Peru marks MediPharm Labs’ first Latin American export following successful exports to Australia and Ge…
MediPharm Labs exports commercial shipment of medical cannabis products approved by the Australian Therapeutic Goods Administration (TGA) to patients in Germany An export milestone for the Australian cannabis industry as an export hubGerma…
BARRIE, Ontario, April 01, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and…
BARRIE, Ontario, March 31, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation and deriva…
TORONTO, March 29, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillat…
BARRIE, Ontario, March 26, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction,…
BARRIE, Ontario, March 26, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction,…
Quebec marks the Company’s 7th provincial distribution supply agreementMediPharm Labs expanded distribution footprint represents potential coverage of an estimated 95%+ of retail market in CanadaMediPharm Labs will be selling its MediPharm…
TORONTO, March 08, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”), a global leader in specialized, research-driven cannabis extraction, distillation and derivative pr…
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, March 05, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a g…
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, March 02, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a g…